JP2015504677A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015504677A5 JP2015504677A5 JP2014552323A JP2014552323A JP2015504677A5 JP 2015504677 A5 JP2015504677 A5 JP 2015504677A5 JP 2014552323 A JP2014552323 A JP 2014552323A JP 2014552323 A JP2014552323 A JP 2014552323A JP 2015504677 A5 JP2015504677 A5 JP 2015504677A5
- Authority
- JP
- Japan
- Prior art keywords
- tcf
- biomarker
- level
- subject
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261586672P | 2012-01-13 | 2012-01-13 | |
| US61/586,672 | 2012-01-13 | ||
| PCT/US2013/021197 WO2013106686A1 (en) | 2012-01-13 | 2013-01-11 | Biomarkers for the treatment of hepatocellular carcinoma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015504677A JP2015504677A (ja) | 2015-02-16 |
| JP2015504677A5 true JP2015504677A5 (https=) | 2016-03-03 |
Family
ID=47604231
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014552323A Pending JP2015504677A (ja) | 2012-01-13 | 2013-01-11 | 肝細胞癌治療のためのバイオマーカー |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US8901110B2 (https=) |
| EP (1) | EP2802877A1 (https=) |
| JP (1) | JP2015504677A (https=) |
| CN (1) | CN104737021A (https=) |
| AU (1) | AU2013202104B2 (https=) |
| CA (1) | CA2871535A1 (https=) |
| MX (1) | MX2014008388A (https=) |
| WO (1) | WO2013106686A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2428513T3 (en) | 2006-09-26 | 2017-08-21 | Celgene Corp | 5-substituted quinazolinone derivatives as anti-cancer agents |
| JP5959543B2 (ja) | 2011-03-11 | 2016-08-02 | セルジーン コーポレイション | ３−（５−アミノ−２−メチル−４−オキソ−４ｈ−キナゾリン−３−イル）−ピペリジン−２，６−ジオンの固体形態、並びにそれらの医薬組成物及び使用 |
| ES2814952T3 (es) | 2012-09-04 | 2021-03-29 | Celgene Corp | Isotopólogos de 3-(5-amino-2-metil-4-oxoquinazolin-3(4H)-il) piperidina-2-6-diona y métodos de preparación de los mismos |
| IL278381B2 (en) * | 2013-12-06 | 2024-08-01 | Celgene Corp | Methods for determining the effectiveness of a drug for the treatment of diffuse large B-cell lymphoma, multiple myeloma, and myeloid cancer |
| CN103645259B (zh) * | 2013-12-12 | 2015-03-11 | 深圳海王药业有限公司 | 一种同时测定泊马度胺及其有关物质的方法 |
| WO2016060702A1 (en) * | 2014-10-13 | 2016-04-21 | Celgene Corporaton | Methods for treating solid tumors and the use of biomarkers as a predictor of clinical sensitivity to immunomodulatory therapies |
| US10537585B2 (en) | 2017-12-18 | 2020-01-21 | Dexcel Pharma Technologies Ltd. | Compositions comprising dexamethasone |
| CN108048568B (zh) * | 2017-12-25 | 2021-02-02 | 贵州省人民医院 | Plcd4基因作为胃腺癌转移诊断标志物的用途 |
| CN109266747B (zh) * | 2018-09-21 | 2021-07-27 | 中国医学科学院北京协和医院 | 与i型神经纤维瘤合并脊柱畸形病相关gpr56及其应用 |
| EP3863615A4 (en) * | 2018-10-14 | 2022-08-03 | Lantern Pharma Inc. | METHODS OF TREATMENT OF CANCERS WITH SOLID TUMORS USING ILLUDINS AND BIOMARKERS |
| US20220289821A1 (en) * | 2018-11-29 | 2022-09-15 | Trillium Therapeutics Inc | Biomarkers for cd47 blockade therapy |
| CN116064810A (zh) * | 2022-11-10 | 2023-05-05 | 杭州医学院 | CD24作为Hippo通路失活亚型肝细胞癌生物标志物的应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1166651C (zh) * | 2001-06-08 | 2004-09-15 | 北京大学药学院 | 具有抗炎和抗肿瘤作用r-双或糖苯丙异硒唑取代化合物 |
| US7803783B2 (en) * | 2002-12-06 | 2010-09-28 | The Board Of Trustees Of The Leland Stanford Junior University | Use of WNT inhibitors to augment therapeutic index of chemotherapy |
| WO2011109237A2 (en) * | 2010-03-02 | 2011-09-09 | Emory University | Uses of noscapine and derivatives in subjects diagnosed with fap |
-
2013
- 2013-01-11 EP EP13701319.9A patent/EP2802877A1/en not_active Withdrawn
- 2013-01-11 CA CA2871535A patent/CA2871535A1/en not_active Withdrawn
- 2013-01-11 JP JP2014552323A patent/JP2015504677A/ja active Pending
- 2013-01-11 AU AU2013202104A patent/AU2013202104B2/en not_active Ceased
- 2013-01-11 MX MX2014008388A patent/MX2014008388A/es unknown
- 2013-01-11 CN CN201380014334.8A patent/CN104737021A/zh active Pending
- 2013-01-11 US US13/740,012 patent/US8901110B2/en active Active
- 2013-01-11 WO PCT/US2013/021197 patent/WO2013106686A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015504677A5 (https=) | ||
| Voigt et al. | Serotonin controlling feeding and satiety | |
| Bermudez et al. | Gli1 mediates lung cancer cell proliferation and Sonic Hedgehog-dependent mesenchymal cell activation | |
| Hu et al. | Cytosolic DNA sensor cGAS plays an essential pathogenetic role in pressure overload-induced heart failure | |
| Newman et al. | Leptin–cytokine crosstalk in breast cancer | |
| IL278381B1 (en) | Methods for determining drug efficacy for the treatment of diffuse large b-cell lymphoma, multiple myeloma, and myeloid cancers | |
| JP2016500110A5 (https=) | ||
| Vaňhara et al. | Growth/differentiation factor-15: prostate cancer suppressor or promoter? | |
| Wang et al. | The non-canonical role of vascular endothelial growth factor-C axis in cancer progression | |
| JP2019216716A5 (https=) | ||
| Lin et al. | Endostatin and kidney fibrosis in aging: a case for antagonistic pleiotropy? | |
| Yang et al. | Pharmaco-transcriptomic correlation analysis reveals novel responsive signatures to HDAC inhibitors and identifies Dasatinib as a synergistic interactor in small-cell lung cancer | |
| JP2011501176A5 (https=) | ||
| IL247111B1 (en) | Preventive or therapeutic agent for kidney disease | |
| JP2015521050A5 (https=) | ||
| Yue et al. | Rnd3 haploinsufficient mice are predisposed to hemodynamic stress and develop apoptotic cardiomyopathy with heart failure | |
| EA202191354A1 (ru) | Способы и композиции для прогнозирования ответа на терапию воспалительного заболевания кишечника | |
| MX2014008388A (es) | Biomarcadores para el tratamiento de carcinoma hepatocelular. | |
| EA201692497A1 (ru) | Биомаркеры ответа на ингибиторы ezh2 | |
| Montano‐Loza | Skeletal muscle abnormalities and outcomes after liver transplantation | |
| Hiwasa | Association of serum antibody levels against TUBB2C with diabetes and cerebral infarction | |
| Kato et al. | Lactate dehydrogenase and hemolysis in sickle cell disease | |
| MX380889B (es) | Lactoferrina para uso en el diagnóstico o el pronóstico de la enfermedad de alzheimer o en el diagnóstico de la enfermedad de parkinson. | |
| JP2018004657A5 (https=) | ||
| Kotelevets et al. | The Rac1 splice form Rac1b favors mouse colonic mucosa regeneration and contributes to intestinal cancer progression |